Smith & Nephew SNATS (NYSE:SNN) Stock Rating Upgraded by Wall Street Zen

Smith & Nephew SNATS (NYSE:SNNGet Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Sunday, Wall Street Zen reports.

SNN has been the subject of several other research reports. Kepler Capital Markets downgraded shares of Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research note on Thursday, June 4th. Bank of America cut Smith & Nephew SNATS from a “buy” rating to a “neutral” rating in a research report on Tuesday, September 8th. Morgan Stanley lowered Smith & Nephew SNATS from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, September 2nd. Zacks Research upgraded Smith & Nephew SNATS from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 8th. Finally, Barclays downgraded Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $31.91.

View Our Latest Stock Analysis on SNN

Smith & Nephew SNATS Stock Up 3.3%

Shares of NYSE SNN opened at $28.40 on Friday. The business has a 50-day moving average of $29.89 and a two-hundred day moving average of $31.08. Smith & Nephew SNATS has a 1 year low of $27.23 and a 1 year high of $37.78. The company has a quick ratio of 1.11, a current ratio of 2.14 and a debt-to-equity ratio of 0.62.

Institutional Trading of Smith & Nephew SNATS

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Clearstead Trust LLC acquired a new position in Smith & Nephew SNATS during the second quarter worth $25,000. Addison Advisors LLC purchased a new position in Smith & Nephew SNATS in the second quarter worth $43,000. Allworth Financial LP acquired a new stake in Smith & Nephew SNATS in the second quarter valued at $48,000. Global Retirement Partners LLC lifted its holdings in Smith & Nephew SNATS by 811.6% in the fourth quarter. Global Retirement Partners LLC now owns 1,887 shares of the medical equipment provider’s stock valued at $62,000 after acquiring an additional 1,680 shares during the period. Finally, Huntington National Bank boosted its position in shares of Smith & Nephew SNATS by 36.4% during the 4th quarter. Huntington National Bank now owns 1,928 shares of the medical equipment provider’s stock worth $63,000 after purchasing an additional 514 shares in the last quarter. 25.64% of the stock is owned by hedge funds and other institutional investors.

About Smith & Nephew SNATS

(Get Free Report)

Smith & Nephew plc is a global medical technology company headquartered in the United Kingdom. Founded in 1856 by Thomas James Smith in Hull, the company initially operated as a pharmacy business before expanding into healthcare products and medical devices.

The company develops and manufactures technologies used in orthopaedic reconstruction, sports medicine, and advanced wound management. Its products include joint replacement systems, trauma and extremities devices, arthroscopic equipment, surgical repair technologies, wound dressings, negative-pressure wound therapy systems, and other products designed to support tissue healing and surgical care.

Smith & Nephew serves hospitals, healthcare professionals, and patients in markets around the world.

Featured Stories

Analyst Recommendations for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS and related companies with MarketBeat.com's FREE daily email newsletter.